Western blot results showed that knockdown of BCL2 remedied F. nucleatum-reduced Caspase-3 and GSDME activation in chemotherapy-treated CRC cells (Figures 3a & 3b, Figure S2C). The gene discussed is BCL2; the disease is colorectal carcinoma.